Abstract
Fontan-associated protein losing enteropathy is a challenge to treat and is a major contributor to morbidity and mortality in patients with palliated single ventricle. Numerous strategies for management have been proposed, with confusion as to how best to stratify and implement care among the many treatments available. Medical management can be helpful in some, while novel lymphatic interventions hold potential for remission with good results. We review our institutional approach to protein losing enteropathy after Fontan operation and provide a suggested algorithm and pathway for effective care.
Original language | English |
---|---|
Pages (from-to) | 92-96 |
Number of pages | 5 |
Journal | World Journal for Pediatric and Congenital Heart Surgery |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Fontan
- lymphatics
- protein losing enteropathy
- single ventricle